Experience of successful autologous hematopoietic stem cell transplantation in patients with an unfavorable prognosis of systemic scleroderma

Experience of successful autologous hematopoietic stem cell transplantation in patients with an unfavorable prognosis of systemic scleroderma

One of the methods of treating severe forms of systemic scleroderma is hematopoietic stem-cell autotransplantation (auto-HSCT). The article describes two clinical cases of auto-HSCT followed by rituximab (RTM) therapy in patients with diffuse systemic scleroderma with progressive interstitial lung d...

Full description

Bibliographic Details
Main Authors:	V. I. Mazurov, A. L. Maslyanskiy, K. E. Zotkina, S. S. Benevolenskaya, D. V. Motorin, A. Yu. Zaritskiy, E. A. Vasilenko, A. A. Vasilenko, A. M. Titova
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2022-07-01
Series:	Научно-практическая ревматология
Subjects:	autologous bone marrow transplantation systemic scleroderma interstitial lung disease
Online Access:	https://rsp.mediar-press.net/rsp/article/view/3188

Similar Items

Total Facial Autologous Fat Grafting for Treating Skin Manifestations in Scleroderma
by: Ariel Berl, et al.
Published: (2022-11-01)

Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016-11-01)

UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT
by: R. T. Alekperov, et al.
Published: (2014-09-01)

Scleroderma-overlap syndromes: capillaroscopy, laboratory, and clinical manifestations and follow-up compared to scleroderma patients
by: Saeedeh Shenavandeh, et al.
Published: (2024-01-01)

Autologous hematopoietic stem cell transplantation improves long-term survival—data from a national registry
by: Norbert Blank, et al.
Published: (2022-11-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Diagnosis and treatment of interstitial lung disease in scleroderma systematica
by: L. P. Ananyeva
Published: (2018-06-01)

IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE)
by: Olga Aleksandrova Koneva
Published: (2010-06-01)

SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION
by: Lyudmila Valeryevna Teplova, et al.
Published: (2010-06-01)

A case of sine scleroderma with parenchymal lung disease
by: Mansoor Karimifar, et al.
Published: (2014-01-01)

Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease
by: Olga Borisovna Ovsyannikova, et al.
Published: (2013-06-01)

Case Report: Exacerbation after fat grafting in patients with active localized scleroderma
by: Shunxin Han, et al.
Published: (2024-08-01)

CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA
by: L P Anan'eva, et al.
Published: (2011-04-01)

The Assessment of Health-Related Quality of Life in Scleroderma-Interstitial Lung Disease
by: Shahrzad M Lari, et al.
Published: (2014-05-01)

The Assessment of Health-Related Quality of Life in Scleroderma-Interstitial Lung Disease
by: Shahrzad M Lari, et al.
Published: (2014-05-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
by: N. A. Shostak, et al.
Published: (2020-05-01)

Drug‐induced interstitial pneumonia after intravesical Bacillus Calmette‐Guerin administration for bladder cancer with scleroderma
by: Fumie Yoshioka, et al.
Published: (2023-03-01)

SCLERODERMA-LIKE MASK OF OSTEOPOIKILIA
by: R G Mukhina, et al.
Published: (2002-04-01)

A case of localized bullous scleroderma
by: A. L. Bakulev, et al.
Published: (2017-08-01)

SCLERODERMA NEPHROPATHY: UNSOLVED PROBLEMS
by: I. E. Bulavko, et al.
Published: (2021-10-01)

Experience with Lipofilling in Children with Localized Scleroderma: Case Study
by: Alina R. Misbakhova, et al.
Published: (2024-11-01)

Cytokines and autologic bone marrow mononuclears in postmyocardial infarction regeneration
by: V. V. Ryabov, et al.
Published: (2007-10-01)

Assessing disease activity in scleroderma-related interstitial lung disease: a review and practical guide to management
by: Tochukwu Adizie, et al.
Published: (2024-09-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Scleroderma and scleroderma-like syndromes
by: Katarzyna Romanowska-Próchnicka, et al.
Published: (2024-06-01)

Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients—High Efficacy of Rituximab
by: Michael Gernert, et al.
Published: (2022-01-01)

Localized scleroderma in children
by: Katarzyna A. Wolska-Gawron, et al.
Published: (2020-06-01)

Association Between Fat Graft Retention and Blood Flow in Localized Scleroderma Patients: A Pilot Study
by: Hayson Chenyu Wang, et al.
Published: (2022-06-01)

Corrigendum: Scleroderma and Scleroderma-like syndromes
by: Katarzyna Romanowska-Próchnicka, et al.
Published: (2024-07-01)

Paraneoplastic scleroderma or neoplasia secondary to scleroderma
by: Alexandru Arvunescu, et al.
Published: (2019-12-01)

Interstitial lung disease in systemic sclerosis (systemic scleroderma)
by: L. P. Ananyeva, et al.
Published: (2021-03-01)

Baricitinib attenuates pulmonary fibrosis in scleroderma mice by regulating macrophage polarization
by: WANG Dandan, et al.
Published: (2024-01-01)

Implantation of autologous fat globules in localized scleroderma and idiopathic lipoatrophy - report of five patients
by: Tiago Pina Zanelato, et al.
Published: (2013-12-01)

BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs
by: Jiahui Jin, et al.
Published: (2021-06-01)

Autologous bone marrow clot as an alternative to autograft for bone defect healing
by: Lim, Z. X. H., et al.
Published: (2019)

Human otopathology in scleroderma
by: Melissa Castillo‐Bustamante, et al.
Published: (2023-12-01)

Biomarkers of interstitial lung disease in systemic scleroderma and their significance
by: D. V. Khorolsky, et al.
Published: (2023-02-01)

Autologous Gradient Formation under Differential Interstitial Fluid Flow Environments
by: Caleb A. Stine, et al.
Published: (2022-01-01)

CLINICAL SIGNIFICANCE OF EXTRACORPOREAL PHOTOCHEMOTHERAPY IN COMPLEX TREATMENT OF LOCALIZED SCLERODERMA
by: O. A. Fomina, et al.
Published: (2016-02-01)

Scleroderma-panniculitis: view of the rheumatologist
by: A. S. Potapova, et al.
Published: (2021-04-01)